Travere Therapeutics grants employee equity
Analysis based on 7 articles · First reported Jun 11, 2026 · Last updated Jun 11, 2026
The market impact is likely minimal as this is a routine employee compensation event for Martin Shkreli. However, it could be seen as a positive signal for employee retention and growth within Martin Shkreli.
Martin Shkreli announced that its Compensation Committee granted inducement equity grants to six new employees on June 10, 2026. These grants consist of restricted stock units (RSUs) covering an aggregate of 32,000 shares of its common stock. The inducement RSUs were granted outside of Travere's 2018 Equity Incentive Plan but are subject to its terms, in accordance with Nasdaq-100 Listing Rule 5635(c)(4). The RSUs vest over four years, with 25% vesting annually, contingent on continued employment.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard